{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:06:30Z","timestamp":1773889590027,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T00:00:00Z","timestamp":1438732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center Poland","award":["2011\/03\/B\/NZ2\/01396"],"award-info":[{"award-number":["2011\/03\/B\/NZ2\/01396"]}]},{"name":"NIH\/NCI","award":["NIH\/NCI CA134458"],"award-info":[{"award-number":["NIH\/NCI CA134458"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic myeloid leukemia (CML) cells express the active BCR-ABL1 protein, which has been targeted by imatinib in CML therapy, but resistance to this drug is an emerging problem. BCR-ABL1 induces endogenous oxidative stress promoting genomic instability and imatinib resistance. In the present work, we investigated the extent of oxidative stress, DNA damage, apoptosis and expression of apoptosis-related genes in  BCR-ABL1 cells sensitive and resistant to imatinib. The resistance resulted either from the Y253H mutation in the BCR-ABL1 gene or incubation in increasing concentrations of imatinib (AR). UV irradiation at a dose rate of 0.12 J\/(m2\u00b7s) induced more DNA damage detected by the T4 pyrimidine dimers glycosylase and hOGG1, recognizing oxidative modifications to DNA bases in imatinib-resistant than -sensitive cells. The resistant cells displayed also higher susceptibility to UV-induced apoptosis. These cells had lower native mitochondrial membrane potential than imatinib-sensitive cells, but UV-irradiation reversed that relationship. We observed a significant lowering of the expression of the succinate dehydrogenase (SDHB) gene, encoding a component of the complex II of the mitochondrial respiratory chain, which is involved in apoptosis sensing. Although detailed mechanism of imatinib resistance in AR cells in unknown, we detected the presence of the Y253H mutation in a fraction of these cells. In conclusion, imatinib-resistant cells may display a different extent of genome instability than their imatinib-sensitive counterparts, which may follow their different reactions to both endogenous and exogenous DNA-damaging factors, including DNA repair and apoptosis.<\/jats:p>","DOI":"10.3390\/ijms160818111","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T05:43:13Z","timestamp":1439876593000},"page":"18111-18128","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["UV Differentially Induces Oxidative Stress, DNA Damage and Apoptosis in BCR-ABL1-Positive Cells Sensitive and Resistant to Imatinib"],"prefix":"10.3390","volume":"16","author":[{"given":"Ewelina","family":"Synowiec","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazyna","family":"Hoser","sequence":"additional","affiliation":[{"name":"Department of Clinical Cytobiology, Medical Center for Postgraduate Education, Marymoncka 99, 01-813 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Wojcik","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta","family":"Pawlowska","sequence":"additional","affiliation":[{"name":"Department of Orthodontics, Medical University of Lodz, Pomorska 251, 92-216 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Skorski","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA 19140, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"B\u0142asiak","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmch.2014.11.002","article-title":"Recent advances in cancer therapeutics","volume":"54","author":"Chessum","year":"2015","journal-title":"Prog. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tips.2014.09.007","article-title":"Advances in kinase targeting: Current clinical use and clinical trials","volume":"35","author":"Zhang","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jabbour, E., Kantarjian, H., and Cortes, J. (2015). Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: An evolving treatment paradigm. Clin. Lymphoma Myeloma Leuk.","DOI":"10.1016\/j.clml.2015.03.006"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ddtec.2014.03.003","article-title":"Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia","volume":"11","author":"Balabanov","year":"2014","journal-title":"Drug Discov. Today Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/03093640701859089","article-title":"BCR\/ABL, DNA damage and DNA repair: Implications for new treatment concepts","volume":"49","author":"Skorski","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/leu.2008.78","article-title":"BCR\/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress","volume":"22","author":"Koptyra","year":"2008","journal-title":"Leukemia"},{"key":"ref_7","first-page":"2791","article-title":"Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70\/86 heterodimer","volume":"62","author":"Gaymes","year":"2002","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","article-title":"BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance","volume":"108","author":"Koptyra","year":"2006","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mrgentox.2005.10.010","article-title":"Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR\/ABL kinase-mediated DNA repair","volume":"603","author":"Majsterek","year":"2006","journal-title":"Mutat. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mrgentox.2008.06.002","article-title":"STI571 reduces NER activity in BCR\/ABL-expressing cells","volume":"654","author":"Sliwinski","year":"2008","journal-title":"Mutat. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-07-6858","article-title":"BCR\/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations","volume":"68","author":"Stoklosa","year":"2008","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s11033-009-9730-0","article-title":"BCR\/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells","volume":"37","author":"Poplawski","year":"2010","journal-title":"Mol. Biol. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/leu.2012.294","article-title":"BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability","volume":"27","author":"Slupianek","year":"2013","journal-title":"Leukemia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/leu.2014.249","article-title":"AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells","volume":"28","author":"Flis","year":"2014","journal-title":"Leukemia"},{"key":"ref_15","first-page":"208","article-title":"Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: An update","volume":"810","author":"Reichrath","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1038\/sj.onc.1205743","article-title":"DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way","volume":"21","author":"Kulms","year":"2002","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.freeradbiomed.2013.12.021","article-title":"Induction of bystander effects by UVA, UVB, and UVC radiation in human fibroblasts and the implication of reactive oxygen species","volume":"68","author":"Widel","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1128\/MCB.22.12.4189-4201.2002","article-title":"Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G2\/M phase, and protection from apoptosis","volume":"22","author":"Slupianek","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/onc.2012.203","article-title":"Targeting abnormal DNA double strand break repair in tyrosine kinase inhibitor-rfesistant chronic myeloid leukemias","volume":"32","author":"Tobin","year":"2013","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2012-11-466938","article-title":"Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells","volume":"121","author":"Schemionek","year":"2013","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1039\/b924712b","article-title":"UVA-induced cyclobutane pyrimidine dimers in DNA: A direct photochemical mechanism?","volume":"8","author":"Mouret","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood-2002-10-3207","article-title":"p210 BCR\/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation","volume":"102","author":"Canitrot","year":"2003","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ajh.21726","article-title":"XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia","volume":"85","author":"Guillem","year":"2010","journal-title":"Am. J. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mrfmmm.2009.08.004","article-title":"Regulation of damage recognition in mammalian global genomic nucleotide excision repair","volume":"685","author":"Sugasawa","year":"2010","journal-title":"Mutat. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3109\/10428194.2012.681654","article-title":"DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells","volume":"53","author":"Dinis","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nrm1443","article-title":"Apoptosis and genomic instability","volume":"5","author":"Zhivotovsky","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/onc.2012.556","article-title":"Various modes of cell death induced by DNA damage","volume":"32","author":"Surova","year":"2013","journal-title":"Oncogene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/cncr.20758","article-title":"Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines","volume":"103","author":"Desplat","year":"2005","journal-title":"Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.cdd.4401231","article-title":"Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis","volume":"10","author":"Gottlieb","year":"2003","journal-title":"Cell. Death Differ."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbabio.2012.09.009","article-title":"Respiratory chain complex II as general sensor for apoptosis","volume":"1827","author":"Grimm","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1016\/j.febslet.2010.07.013","article-title":"The fast-mobility isoform of mouse Mcl-1 is a mitochondrial matrix-localized protein with attenuated anti-apoptotic activity","volume":"584","author":"Huang","year":"2010","journal-title":"FEBS Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1004414","DOI":"10.1371\/journal.pgen.1004414","article-title":"ATRA-induced cellular differentiation and CD38 expression inhibits acquisition of BCR-ABL mutations for CML acquired resistance","volume":"10","author":"Wang","year":"2014","journal-title":"PLoS Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","article-title":"Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia","volume":"25","author":"Bixby","year":"2011","journal-title":"Leukemia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16649","DOI":"10.3390\/ijms150916649","article-title":"Dexamethasone and 1,2,5-dihydroxyvitamin D3 reduce oxidative stress-related DNA damage in differentiating osteoblasts","volume":"15","author":"Pawlowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/mutage\/17.6.489","article-title":"Repair of oxidative DNA damage: Assessing its contribution to cancer prevention","volume":"17","author":"Collins","year":"2002","journal-title":"Mutagenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative Ct method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/8\/18111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:50:13Z","timestamp":1760215813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/8\/18111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,5]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"alternative-id":["ijms160818111"],"URL":"https:\/\/doi.org\/10.3390\/ijms160818111","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,5]]}}}